These trials were selected based on their potential effect to the field of nephrology.
ASN Annual Meeting to highlight 6 late-breaking clinical trials on nephrology Six late-breaking clinical trials have already been accepted for demonstration next week during the American Culture of Nephrology’s 43rd Annual Conference and Scientific Exposition in Denver, CO. These trials were selected based on their potential effect to the field of nephrology. The trials will be presented on Saturday, November 20 in the Wells Fargo Theater of the Colorado Convention Center from 10:30 am – 12:30 pm MT in the next order: Effects of Nocturnal House Hemodialysis: The Frequent Hemodialysis Network Trials Effect of Bardoxolone Methyl on Renal Function in Individuals with Persistent Kidney Disease and Type 2 Diabetes Mellitus Results of the Multicenter FSGS Medical Trial in Kids and ADULTS Primary Protection and Efficacy Outcomes from Four Phase 3 Randomized, Active-controlled, Open-label Research of Hematide/Peginesatide among CKD Dialysis and Nondialysis Patients Prevention of Dialysis Catheter Lumen Occlusion with RT-PA versus Heparin : A Randomized Trial Should We Reduce LDL Cholesterol in Individuals with Persistent Kidney Disease? The Outcomes of the Study of Center and Renal Security These presentations will also be shown at a press briefing on Saturday, November 20 from 9:15 am – 10:15 am MT in Room 208 of the Colorado Convention Center http://www.dapoxetineforsale.com/ .